Sign In
Buy RGEN
$145.23
+6.83 (+4.93%)
At Close: Jun 25, 2026
A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175.89 vs Price $145.23
06:46pm, Thursday, 25'th Jun 2026
On June 25, 2026, Repligen Corp (RGEN) shares rose 4.9% to a current price of $145.23. The stock has experienced a 52-week range between $100.99 and $175.77, in
Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors
08:09pm, Monday, 22'nd Jun 2026
On June 22, 2026, Repligen Corp (RGEN) shares fell 4.1% today, bringing the current price to $126.67. The stock has seen a 52-week range of $100.99 to $175.77,
Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Tells Investors
07:58pm, Tuesday, 09'th Jun 2026
On June 09, 2026, Repligen Corp (RGEN) shares rose 3.8% today, closing at $130.10. The stock has fluctuated within a 52-week range of $100.99 to $175.77, indica
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?
12:35pm, Thursday, 04'th Jun 2026
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update
12:15pm, Thursday, 04'th Jun 2026
During the first quarter of 2026, the largest portfolio sector weightings were Health Care and Industrials. RBC Bearings Incorporated, Cognex Corporation and Nebius Group were among the top contributo
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
06:21pm, Wednesday, 03'rd Jun 2026
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Repligen Has A Cleaner Recovery Angle, But With High Valuation
09:15am, Sunday, 31'st May 2026
Repligen Has A Cleaner Recovery Angle, But With High Valuation
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF Score: 79/100
06:47pm, Thursday, 28'th May 2026
On May 28, 2026, Repligen Corp (RGEN) shares rose 8.4% today, bringing the current price to $122.73. The stock has experienced volatility over the past year, tr
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
07:30am, Friday, 22'nd May 2026
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
07:30am, Wednesday, 20'th May 2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
04:11pm, Tuesday, 12'th May 2026
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
07:30am, Thursday, 07'th May 2026
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
12:50pm, Wednesday, 06'th May 2026
RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
02:41pm, Tuesday, 05'th May 2026
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
10:15am, Tuesday, 05'th May 2026
Repligen (RGEN) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.39 per share a year ago.
